Matches in Wikidata for { <http://www.wikidata.org/entity/Q80429580> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q80429580 description "article scientifique publié en 2007" @default.
- Q80429580 description "artículu científicu espublizáu en xunu de 2007" @default.
- Q80429580 description "im Juni 2007 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80429580 description "scientific article published on 01 June 2007" @default.
- Q80429580 description "wetenschappelijk artikel" @default.
- Q80429580 description "наукова стаття, опублікована в червні 2007" @default.
- Q80429580 name "Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system" @default.
- Q80429580 name "Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system" @default.
- Q80429580 type Item @default.
- Q80429580 label "Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system" @default.
- Q80429580 label "Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system" @default.
- Q80429580 prefLabel "Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system" @default.
- Q80429580 prefLabel "Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system" @default.
- Q80429580 P1433 Q80429580-C8B4FD99-E0E2-4572-9EF5-6ABD1FE9CF72 @default.
- Q80429580 P1476 Q80429580-7F57A4A1-F219-490A-95C6-981C01DEE57D @default.
- Q80429580 P2093 Q80429580-18F4BEF7-E933-4BBF-944C-2470D92196A9 @default.
- Q80429580 P2093 Q80429580-2625CA20-3AFF-4CA2-8729-69E1486082C4 @default.
- Q80429580 P2093 Q80429580-7C89E6D9-0871-401F-99A3-E341569F83E1 @default.
- Q80429580 P2093 Q80429580-A02C22C9-2EA8-427A-B716-481FC03EAABE @default.
- Q80429580 P304 Q80429580-58283B09-6E82-4F23-BD03-0BAA32AF4CFF @default.
- Q80429580 P31 Q80429580-7178194E-6BCB-474F-8633-4F4DC1F92AA7 @default.
- Q80429580 P356 Q80429580-47556591-FF75-440B-A803-04DEE3EA12B7 @default.
- Q80429580 P433 Q80429580-B2EE4310-7C01-4597-B72E-28F6E78A9AA1 @default.
- Q80429580 P478 Q80429580-383E99D3-A91A-43E0-B2EA-2B25B0FE5905 @default.
- Q80429580 P50 Q80429580-DAD5F27D-F37F-4825-BA73-D46516A5B747 @default.
- Q80429580 P577 Q80429580-495FFE45-8AD5-4532-8ED6-8488042C9F72 @default.
- Q80429580 P698 Q80429580-DEFDE510-B965-419A-BE2E-0602BB8F0DDB @default.
- Q80429580 P921 Q80429580-24147F19-10C2-404C-988D-9972C9EF5CDA @default.
- Q80429580 P356 TH06-11-0632 @default.
- Q80429580 P698 17549295 @default.
- Q80429580 P1433 Q15724413 @default.
- Q80429580 P1476 "Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system" @default.
- Q80429580 P2093 "Anette L Eilertsen" @default.
- Q80429580 P2093 "Marie-Christine Mowinckel" @default.
- Q80429580 P2093 "Per-Morten Sandset" @default.
- Q80429580 P2093 "Sigurd Liestøl" @default.
- Q80429580 P304 "938-943" @default.
- Q80429580 P31 Q13442814 @default.
- Q80429580 P356 "10.1160/TH06-11-0632" @default.
- Q80429580 P433 "6" @default.
- Q80429580 P478 "97" @default.
- Q80429580 P50 Q63379072 @default.
- Q80429580 P577 "2007-06-01T00:00:00Z" @default.
- Q80429580 P698 "17549295" @default.
- Q80429580 P921 Q412888 @default.